Atlas Trials

Molecular Imaging With Erlotinib and Bevacizumab

Clinical trial NCT01047059 · COMPLETED

Trial details

NCT number
NCT01047059
Sponsor
University of Cologne
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Small-Cell Lung Carcinoma
Start date
2010-01-01
Primary completion
2012-10-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.